<?xml version="1.0" encoding="UTF-8"?>
<p id="Par8">Effective cure in the form of vaccine or therapeutic drug is the need of hour to control the COVID-19 from infecting more people. Many vaccine candidates for COVID-19 are in preclinical stage (
 <ext-link ext-link-type="uri" xlink:href="https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1</ext-link>). The vaccine candidate developed against SARS-CoV should be evaluated against COVID-19 virus for its efficacy in inducing neutralizing antibodies as there is similarity with respect to spike protein.
</p>
